Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shihua Shi

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Cardiovascular Medicine|June 27, 2022
Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled TrialXiaoping Wu, Ming Guo, Shihua Shi, et al.
Biochemical Pharmacology|May 27, 2023
Rosavidin protects against PM2.5-induced lung toxicity via inhibition of NLRP3 inflammasome-mediated pyroptosis by activating the PI3K/AKT pathwayDemei Huang, Nan Jia, Caixia Pei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 24, 2022
Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome-mediated pyroptosis via NLRP3/caspase-1 axis inhibition in miceDemei Huang, Shihua Shi, Yilan Wang, et al.
Ecotoxicology and Environmental Safety|September 17, 2022
Probiotics ameliorates pulmonary inflammation via modulating gut microbiota and rectifying Th17/Treg imbalance in a rat model of PM2.5 induced lung injuryYongcan Wu, Caixia Pei, Xiaomin Wang, et al.
Ecotoxicology and Environmental Safety|May 14, 2022
Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approachYilan Wang, Zherui Shen, Sijing Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2022
Eleutheroside B ameliorated high altitude pulmonary edema by attenuating ferroptosis and necroptosis through Nrf2-antioxidant response signalingYilan Wang, Zherui Shen, Caixia Pei, et al.
International Immunopharmacology|June 18, 2023
Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathwayNan Jia, Zherui Shen, Sijing Zhao, et al.
Phytotherapy Research : PTR|September 13, 2022
Pretreatment with rosavin attenuates PM2.5-induced lung injury in rats through antiferroptosis via PI3K/Akt/Nrf2 signaling pathwayYilan Wang, Sijing Zhao, Nan Jia, et al.
Phytotherapy Research : PTR|July 8, 2023
Effects of adjuvant berberine therapy on acute ischemic stroke: A meta-analysisDan Luo, Baili Yu, Shoukai Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 30, 2023
Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosisZherui Shen, Demei Huang, Nan Jia, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Cardiovascular Medicine|June 27, 2022
Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled TrialXiaoping Wu, Ming Guo, Shihua Shi, et al.
Biochemical Pharmacology|May 27, 2023
Rosavidin protects against PM2.5-induced lung toxicity via inhibition of NLRP3 inflammasome-mediated pyroptosis by activating the PI3K/AKT pathwayDemei Huang, Nan Jia, Caixia Pei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 24, 2022
Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome-mediated pyroptosis via NLRP3/caspase-1 axis inhibition in miceDemei Huang, Shihua Shi, Yilan Wang, et al.
Ecotoxicology and Environmental Safety|September 17, 2022
Probiotics ameliorates pulmonary inflammation via modulating gut microbiota and rectifying Th17/Treg imbalance in a rat model of PM2.5 induced lung injuryYongcan Wu, Caixia Pei, Xiaomin Wang, et al.
Ecotoxicology and Environmental Safety|May 14, 2022
Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approachYilan Wang, Zherui Shen, Sijing Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2022
Eleutheroside B ameliorated high altitude pulmonary edema by attenuating ferroptosis and necroptosis through Nrf2-antioxidant response signalingYilan Wang, Zherui Shen, Caixia Pei, et al.
International Immunopharmacology|June 18, 2023
Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathwayNan Jia, Zherui Shen, Sijing Zhao, et al.
Phytotherapy Research : PTR|September 13, 2022
Pretreatment with rosavin attenuates PM2.5-induced lung injury in rats through antiferroptosis via PI3K/Akt/Nrf2 signaling pathwayYilan Wang, Sijing Zhao, Nan Jia, et al.
Phytotherapy Research : PTR|July 8, 2023
Effects of adjuvant berberine therapy on acute ischemic stroke: A meta-analysisDan Luo, Baili Yu, Shoukai Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 30, 2023
Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosisZherui Shen, Demei Huang, Nan Jia, et al.
Pageof 4